- 奥迪r8App下载奥迪r8App大全
- HookeLaboratories试剂盒ELISA
- HTI(Haematologic Technologies Inc)(haemtech) 玉博代理HTI(...
- bbi 公司_
- 大鼠抗酒石酸酸性磷酸酶5b(TRACP5b)ELISA试剂盒 elisa kit
- 试剂盒进口清关
- 有谁知道: haemtech厂家直采,平行进口,怎么样?
- 世界体外诊断原料供应商大全公司动态
- HTI(Haematologic Technologies Inc)(haemtech)总代理
- HAEMATOLOGIC代理_
- Haematologic Technologies Inc. (HTI)公司凝血酶现货促销 企业动 ...
- 大鼠抗酒石酸酸性磷酸酶5b(TRACP5b)ELISA试剂盒kit说明书_价格...
| Formulation | 20mMTris,150mMNaCl,pH7.4 |
| Storage | -80°C |
| Purity | >95%bySDS-PAGE |
| ActivityDetermination | N/A |
| ShelfLife(properlystored) | 12months |
Theaminoacidsequenceofbovineboneosteocalcin.Thepositionsoftheg-carboxyglutamicacidresiduesareindicatedbygamma.
SampleGelInformation:

| Gel | Novex4-12%Bis-Tris |
|---|---|
| Load | Bovineosteocalcin,1µgperlane |
| Buffer | MES |
| Standard | SeeBluePlus2;Myosin(188kDa),PhosphorylaseB(98kDa),BSA(62kDa),GlutamicDehydrogenase(49kDa),AlcoholDehydrogenase(38kDa),CarbonicAnhydrase(28kDa),MyoglobinRed(17kDa),Lysozyme(14kDa),Aprotinin(6kDa),Insulin,Bchain(3kDa). |
Overview:
Osteocalcin,alsoknownasBone-Gla-Protein(BGP),isasinglechain(Mr=5800)vitaminKdependentproteinproducedbyosteoblastsandfoundinhighconcentrationsinbone(1-4).Post-translationalmodificationbyavitaminKdependentcarboxylaseproducesthreeg-carboxyglutamicacidresiduesatpositions17,21and24.Thematureproteincontains49aminoacidsandasingleintrachaindisulfidebondjoiningCys23toCys29.Thesecondarystructureishighlycalciumdependentandcontains14%α-helix,20%β-sheetand67%randomforminthepresenceofcalcium,and1%α-helix,20%β-sheetand79%randomformintheabsenceofcalcium(4).
BGPbindstophospholipidvesiclesinthepresenceofcalciumions(Kd=6x10-6M)(5).BGPalsobindshydroxyapatiteandisanefficientinhibitorofhydroxyapatiteseededcrystalgrowth,suggestingaregulatoryroleinbonemineralization(6).AlthoughthefundamentalroleofBGPinvivoremainselusive,invitroexperimentationsuggestsrolesinbothboneresorptionandboneformation.BGPhasbeenshowntofunctionasachemo-attractantinaninvitromacrophagemediatedboneresorptionsystem.TheserumconcentrationofBGPhasbeenlinkedtoboneformationrates,andBGPlevelsarecurrentlyusedinresearchassessmentofosteoporosisandothermetabolicbonediseasestates(7).
OsteocalcinispreparedfrombovinebonegenerallyasdescribedbyPriceetal.(1).ThisinvolvesdemineralizationinEDTA,sizeexclusionandionexchangechromatography.Thepurifiedproteinissupplied50%(vol/vol)glycerol/0.01MTris,0.075MNaCl,pH7.4,andshouldbestoredat-20°C.Humanosteocalcinispreparedfromextractsofacid-demineralizedbone,usingimmunoaffinitychromatography.Thehumanproteinissuppliedin0.02MTris,0.15MNaCl,2mMCaCl2,pH7.4andshouldbestoredat-80°C.PurityisdeterminedbySDS-PAGE.
Properties:
| Localization | Bone,plasma | |||||
|---|---|---|---|---|---|---|
| Modeofaction | Unknown | |||||
| Molecularweight | 5,800(1) | |||||
| Extinctioncoefficient |
| |||||
| Isoelectricpoint | 4.0-4.5(8) | |||||
| Structure | Singlechain,oneintrachaindisulfidebond,Cys23-29. | |||||
| Percentcarbohydrate | 0% | |||||
| Post-translationalmodifications | Threeglaresidues,17,21,24 |


